Amgen Inc.
MX ˙ BMV ˙ NL0000888691
SecurityMX:AMGN / Amgen Inc.
InstitutionPaulson Wealth Management Inc.
Latest Disclosed Ownership1,927 shares
Latest Disclosed Value $ 678,015
Paulson Wealth Management Inc. reports 37.74% decrease in ownership of AMGN / Amgen Inc.

On May 8, 2026 - Paulson Wealth Management Inc. filed a 13F-HR form disclosing ownership of 1,927 shares of Amgen Inc. (MX:AMGN) valued at $678,015 USD as of March 31, 2026. The entity filed a previous 13F-HR on February 5, 2026 disclosing 3,095 shares of Amgen Inc.. This represents a change in shares of -37.74% during the quarter.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date
Effective
Date
Form Security Class ID Avg Price
Paid (Est)
Reported
Shares
ΔShares ΔShares
(%)
Reported
Value
(x1000)
ΔValue
(%)
Alloc
(%)
ΔAlloc ΔAlloc (%) Cost Basis
(x1000)
Unrealized
Gain/Loss
(x1000)
2026-05-08 2026-03-31 13F AMGEN COM 031162100 1,927 -1,168 -37.74 678 -33.07 0.1589
2026-02-05 2025-12-31 13F AMGEN COM 031162100 3,095 37 1.21 1,013 17.52 0.2340
2025-11-03 2025-09-30 13F AMGEN COM 031162100 3,058 77 2.58 863 3.61 0.2040
2025-08-06 2025-06-30 13F AMGEN COM 031162100 2,981 1,386 86.90 832 67.74 0.2155
2025-05-12 2025-03-31 13F AMGEN COM 031162100 1,595 -61 -3.68 497 15.08 0.1399
2025-02-13 2024-12-31 13F AMGEN COM 031162100 1,656 -232 -12.29 432 -29.11 0.1178
2024-11-05 2024-09-30 13F AMGEN COM 031162100 1,888 -18 -0.94 608 2.18 0.1628
2024-07-25 2024-06-30 13F AMGEN COM 031162100 1,906 -24 -1.24 596 8.58 0.1738
2024-05-03 2024-03-31 13F AMGEN COM 031162100 1,930 29 1.53 549 0.18 0.1614
2024-02-13 2023-12-31 13F AMGEN COM 031162100 1,901 -1,054 -35.67 548 -31.11 0.1754
2023-11-01 2023-09-30 13F AMGEN COM 031162100 2,955 1,010 51.93 794 84.22 0.2777
2023-08-01 2023-06-30 13F AMGEN COM 031162100 1,945 702 56.48 432 43.67 0.1475
2023-05-09 2023-03-31 13F AMGEN COM 031162100 1,243 190 18.04 300 8.70 0.1336
2023-01-26 2022-12-31 13F AMGEN COM 031162100 1,053 1,053 277 0.1350
2022-11-02 2022-09-30 13F AMGEN COM 031162100 0 -1,305 -100.00 0 -100.00
2022-08-05 2022-06-30 13F AMGEN COM 031162100 1,305 -17 -1.29 318 -0.62 0.1675
2022-05-02 2022-03-31 13F AMGEN COM 031162100 1,322 82 6.61 320 14.70 0.1460
2022-01-28 2021-12-31 13F AMGEN COM 031162100 1,240 1,240 279 0.1246
2021-02-05 2020-12-31 13F AMGEN COM 031162100 0 -1,178 -100.00 0 -100.00
2020-10-14 2020-09-30 13F AMGEN COM 031162100 1,178 1,178 299 0.1931
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.